Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women
Ruanne V. Barnabas(Harvard University), Nelly Mugo(University of Washington), Ouma Congo(Kenya Medical Research Institute), Denise A. Galloway(Fred Hutch Cancer Center), Susan Morrison, Lynda Oluoch(Kenya Medical Research Institute), Elizabeth A. Bukusi(University of California, San Francisco), Hannah Leingang(University of Washington), Maricianah Onono(Kenya Medical Research Institute), Imelda Wakhungu(Kenya Medical Research Institute), Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kate B. Heller(University of Washington), Syovata Kimanthi(Kenya Medical Research Institute), Torin Schaafsma(University of Washington), Connie Celum(University of Washington), Rachel L. Winer(University of Washington), Elizabeth R. Brown(Fred Hutch Cancer Center), R. Scott McClelland(University of Washington), Stephen Cherne, Betty Njoroge(Kenya Medical Research Institute), Leeya F. Pinder(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elena Rechkina(University of Washington), Charlene Biwott(Kenya Medical Research Institute)
Cited by 216
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection
|New England Journal of Medicine|1992|952
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891